6-27309304-C-G

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_033482.4(POM121L2):​c.2867G>C​(p.Gly956Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000309 in 1,551,040 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000019 ( 0 hom. )

Consequence

POM121L2
NM_033482.4 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.698

Publications

0 publications found
Variant links:
Genes affected
POM121L2 (HGNC:13973): (POM121 transmembrane nucleoporin like 2) Predicted to enable nuclear localization sequence binding activity. Predicted to be a structural constituent of nuclear pore. Predicted to be involved in RNA export from nucleus and protein import into nucleus. Predicted to be part of nuclear pore. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.12951079).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
POM121L2NM_033482.4 linkc.2867G>C p.Gly956Ala missense_variant Exon 1 of 1 ENST00000444565.2 NP_258443.2 Q96KW2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
POM121L2ENST00000444565.2 linkc.2867G>C p.Gly956Ala missense_variant Exon 1 of 1 6 NM_033482.4 ENSP00000392726.1 Q96KW2
POM121L2ENST00000429945.1 linkc.216+1793G>C intron_variant Intron 1 of 1 3 ENSP00000415181.1 H7C418

Frequencies

GnomAD3 genomes
AF:
0.000138
AC:
21
AN:
152140
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000639
AC:
1
AN:
156484
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.000125
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000193
AC:
27
AN:
1398900
Hom.:
0
Cov.:
31
AF XY:
0.0000145
AC XY:
10
AN XY:
689916
show subpopulations
African (AFR)
AF:
0.000634
AC:
20
AN:
31558
American (AMR)
AF:
0.0000281
AC:
1
AN:
35618
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25120
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35740
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79136
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49334
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5696
European-Non Finnish (NFE)
AF:
0.00000185
AC:
2
AN:
1078690
Other (OTH)
AF:
0.0000690
AC:
4
AN:
58008
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000138
AC:
21
AN:
152140
Hom.:
0
Cov.:
32
AF XY:
0.000148
AC XY:
11
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.000483
AC:
20
AN:
41432
American (AMR)
AF:
0.00
AC:
0
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68034
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000142
Hom.:
0
Bravo
AF:
0.000140

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Oct 12, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.2867G>C (p.G956A) alteration is located in exon 1 (coding exon 1) of the POM121L2 gene. This alteration results from a G to C substitution at nucleotide position 2867, causing the glycine (G) at amino acid position 956 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
16
DANN
Benign
0.91
DEOGEN2
Benign
0.0084
T
Eigen
Benign
-0.058
Eigen_PC
Benign
-0.26
FATHMM_MKL
Benign
0.070
N
LIST_S2
Benign
0.51
T
M_CAP
Benign
0.0080
T
MetaRNN
Benign
0.13
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.7
L
PhyloP100
0.70
PrimateAI
Benign
0.29
T
PROVEAN
Uncertain
-2.5
D
REVEL
Benign
0.072
Sift
Benign
0.14
T
Sift4G
Benign
0.085
T
Vest4
0.27
MVP
0.10
ClinPred
0.20
T
GERP RS
3.3
Varity_R
0.10
gMVP
0.094
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs868731909; hg19: chr6-27277083; API